There's no COVID-19 cure yet, but health care workers can still count many tiny victories that are making the fight easier.
In the early days of the coronavirus pandemic, doctors "were flying blind" as they tried to treat a disease with mysterious symptoms and very little research, Jose Pascual, a critical care doctor at the University of Pennsylvania Health System, tells The Washington Post. But health care workers everywhere have since "devised a toolbox, albeit a limited and imperfect one, of drugs and therapies" they believe are improving patients' chances of survival every day, the Post reports.
When Penn Medicine hospitals first started receiving coronavirus patients, they were ready to focus on patients' lungs, so they stockpiled ventilators and trained workers to treat breathing complications, Pascual told the Post. Yet coronavirus patients soon started throwing doctors "curveballs" in the form of kidney, liver, skin, and brain complications, Pascual described. Doctors around the country also noted how seemingly healthy patients could actually have "abnormally low oxygen levels," the Post writes.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But those shocking developments quickly became lessons. Hospitals started quickly measuring oxygen levels in any suspected coronavirus patients, and learned how to boost breathing support for patients. They knew to look for unexpected side effects in other parts of the body. And after some once-promising drugs proved unhelpful in the coronavirus fight, doctors have been able to rule them out in favor of more effective drugs.
Of course, there's still no definitive cure or even treatment regimen for COVID-19. Doctors are all using experimental approaches that will have to be further researched through randomized clinical trials before they're approved for general use. Read more at The Washington Post.
-
‘Congratulations on your house, but maybe try a greyhound instead’Instant Opinion Opinion, comment and editorials of the day
-
How climate change poses a national security threatThe explainer A global problem causing more global problems
-
The 5 best TV shows about the mobThe Week Recommends From the show that launched TV’s golden age to a Batman spin-off, viewers can’t get enough of these magnificent mobsters
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
